Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
product_variation
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
product_variation

Latest News

  • 23
    Jul

    baseclick is joining INT2ACT project as an industry partner to advance nucleic acid technologies

    The INT2ACT (Innovative Nucleic Acids Technologies for Analysis, Detection and Treatment) consortium has been awarded funding under the prestigious Marie Skłodowska-Curie Actions (MSCA) program by

    MORE →

  • 18
    Jul

    Enhancing Fibrotic Lung Research: How baseclick’s Sugar-Ligand Technology Advances Drug Targeting

    Pulmonary fibrosis remains one of the most challenging and poorly treatable chronic diseases. Despite promising in vitro findings, many anti-fibrotic compounds fail in clinical translation

    MORE →
  • ClickSeq for RNA & DNA Sequencing Applications

    2
    Jul

    Upcoming Webinar: Solving Nucleic Acid Sequencing Challenges: ClickSeq Applications in RNA & DNA Library Preparation

    We are pleased to invite you to our upcoming webinar featuring the latest advancements in ClickSeq technology, a click-chemistry-driven platform for RNA and now DNA

    MORE →

  • 24
    Jun

    Novartis Acquires Regulus Therapeutics to Advance microRNA-Based Therapy for ADPKD

    Novartis has announced its acquisition of Regulus Therapeutics in a transaction valued at up to $1.7 billion. This strategic move aims to advance farabursen, an

    MORE →

  • 6
    Jun

    baseclick GmbH secures revolutionary U.S. Patent for Click modified mRNA Technology

    Development of innovative platform enhances mRNA therapeutics with improved stability, targeting and delivery Neuried, Germany (June 06, 2025) baseclick GmbH, a leader in nucleic acid

    MORE →